Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia

The objective of this study was to design and validate a bedside decision instrument to be used by patients with chronic myeloid leukemia and their physicians in deciding between the therapeutic alternatives of bone marrow transplantation and conservative management during the early phase of disease.

[1]  W. Mackillop,et al.  Cancer patients' perceptions of their disease and its treatment. , 1988, British Journal of Cancer.

[2]  W. Gregory,et al.  Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. , 1990, BMJ.

[3]  F. Mosteller,et al.  Quantifying Probabilistic Expressions , 1990 .

[4]  T E Hughes,et al.  Patient involvement in health care. A procedural justice viewpoint. , 1991, Medical care.

[5]  R. Kurzrock,et al.  Therapy of chronic myelogenous leukemia: chemotherapy and interferons. , 1988, Seminars in hematology.

[6]  David V. Budescu,et al.  Dyadic decisions with numerical and verbal probabilities , 1990 .

[7]  E. Thomas,et al.  Indications for marrow transplantation in chronic myelogenous leukemia. , 1989, Blood.

[8]  C. Stocking,et al.  Sex or survival: trade-offs between quality and quantity of life. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  B. McNeil,et al.  Fallacy of the five-year survival in lung cancer. , 1978, The New England journal of medicine.

[10]  L. Siminoff,et al.  Effects of outcome framing on treatment decisions in the real world: impact of framing on adjuvant breast cancer decisions. , 1989, Medical decision making : an international journal of the Society for Medical Decision Making.

[11]  G. Rose.  Reflections on the changing times. , 1990, BMJ.

[12]  C. Stocking,et al.  Bone marrow transplantation for sickle cell disease. A study of parents' decisions. , 1991, The New England journal of medicine.

[13]  B. McNeil,et al.  Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. , 1981, The New England journal of medicine.

[14]  K. M. Taylor,et al.  "Telling bad news": physicians and the disclosure of undesirable information. , 2008, Sociology of Health and Illness.

[15]  D. Golde,et al.  Chronic myelogenous leukemia: recent advances. , 1985, Blood.

[16]  S. Wartman,et al.  When competent patients make irrational choices. , 1990, The New England journal of medicine.

[17]  B. Cassileth,et al.  Information and participation preferences among cancer patients. , 1980, Annals of internal medicine.

[18]  R. Hoffmann,et al.  Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. , 1988 .

[19]  L. Siminoff,et al.  Doctor-patient communication about breast cancer adjuvant therapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Mauro,et al.  Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. , 1985, Blood.

[21]  Amiram Gafni,et al.  The Optimal Treatment Strategy-A Patient's Perspective , 1987 .

[22]  G. Santos.  Bone marrow transplantation in hematologic malignancies.Current status , 1990, Cancer.

[23]  D. Streiner,et al.  Health Measurement Scales: A practical guide to thier development and use , 1989 .

[24]  A. Gafni,et al.  A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer , 1992, Annals of Internal Medicine.